Retinal Age as Disease Biomarker - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min

Share

Objective:

To evaluate the accuracy of a deep learning model in estimating biological aging through retinal imaging and its implications for systemic disease screening.

Key Findings:
  • The model demonstrated improved accuracy over previous systems.
  • Patients with diabetes, cardiac disease, or a history of stroke had significantly higher retinal age gaps.
  • The model's predictions focused on the optic disc, macula, and major vascular arcades, indicating their relevance to systemic vascular health.
Interpretation:

Limitations:
  • The study population was predominantly Asian, affecting generalizability.
  • Performance declined in more diverse datasets.
  • Image quality and acquisition variability influenced accuracy.
Conclusion:

Original Source(s)

Retinal Age as Disease Biomarker

  • May 27, 2026

Related Content

Robust and reproducible population receptive field mapping in patients with retinal pathologies

Association of the apolipoproteins with retinal arteriosclerosis in a health examination population

Retinal Features May Reveal Depression

In a UK Biobank cohort, thinner ganglion cell-inner plexiform layer and macular measurements were associated with incident depression over more than a decade of follow-up, while no independent association emerged for anxiety disorders.